Pri-Med Podcasts

What’s on the Horizon for Heart Failure with Reduced Ejection Fraction? (Podcast)

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Curriculum/gluckman-merck-hf-2   Guest: Ty J. Gluckman, MD, FACC, FAHA

COVID-19 Update: Vaccines, Working From Home, and So Much More - Frankly Speaking Ep 202

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-202
Overview: There are many aspects of the COVID-19 pandemic that clinicians need to stay current with. In this episode we will briefly review ten hot topics related to COVID-19, including but not limited to: testing, vaccines, and reinfection.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Is it Time to Stop Checking LDL-C? - Frankly Speaking Ep 201

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-201
Overview: Various organizations develop guidelines to assist with patient care. This episode will review the most significant changes to the U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) Clinical Practice Guidelines for the Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato

Pain Points: Persistent Postoperative Pain

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/rems-podcast-6 Overview: The vast majority of opioid overdoses are inadvertent. While not a substitute for emergency medical care, naloxone can reduce the risk of opioid overdose mortality. It is important for medical professionals, patients, and families to become familiar with naloxone use. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Guest:  Oscar A. De Leon-Casasola, MD

Favorite Podcast of the Last 200! - Frankly Speaking Ep 200

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200
Overview: Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review  their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful.  
Guest: Alan Ehrlich, MD, FAAFP; Robert A. Baldor, MD, FAAFP; Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien, PhD, ANP-BC
Music Credit: Richard Onorato

Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199
Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Advances in Men’s Health in the Last 25 Years Episode 5: Coffee with Chopra

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/ccb-mens-health Overview: Join Dr. Sanjiv Chopra in this installment of Coffee with Chopra, as he interviews urologist and author, Dr. Abraham Morgentaler, about topics relevant to Men’s Health including prostate cancer, male sexuality, testosterone replacement therapy, and the concept of “male menopause”. Guest: Sanjiv Chopra, MD, MACP Abraham Morgentaler, MD, FACS 

GLP-1 Receptor Agonists: Overcoming Barriers (Podcast)

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/pmi-glp1-podcast-2 Overview: With the growing role of GLP-1 RAs in the management of diabetes, primary care providers are likely to find themselves discussing this class of medications with their patients. In this podcast, Dr. Michelle Magee will focus on barriers that patients may face to starting a GLP-1 RA and common questions that emerge in patient teaching. Faculty will review ways to troubleshoot these challenges and empower the clinician to engage in effective dialogue around this drug class. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/18/2020 and they are subject to change as new information is published. Guest: Michelle F. Magee, MD, MBBCh, BAO, LRCPSI

Updates to Influenza Management in 2020 and Beyond: Your Questions Answered (FAQ Podcast)

Overview: Join infectious disease specialist, Dr. Daniel Solomon, in the last episode of a 3-part podcast series, as he discusses important concepts related to influenza that are especially relevant in 2020 during the COVID pandemic. During this episode, he will answer frequently asked questions that are compiled from previous Pri-Med activities on the topic of influenza. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 10/13/2020 and they are subject to change as new information is published. Guest: Daniel A. Solomon, MD

“Just a Spoonful of Honey”: Evidence Supporting Honey for URTI Symptom Relief - Frankly Speaking Ep 198

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-198
Overview: Upper respiratory tract infections (URTI) are one of the most common conditions seen in primary care. Effective treatments for this acute, bothersome illness are limited; inappropriate antibiotic prescribing and use of therapeutics with little evidence of effectiveness are common. Join our discussion as we discuss a recent meta-analysis from the BMJ which suggests that honey, in any form, is superior to usual, common treatment for URTIs.
Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato